The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114718142 11471814 2 F 20160715 20150908 20160728 PER US-BAYER-2015-410013 BAYER 76.00 YR E M Y 0.00000 20160728 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114718142 11471814 1 PS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 UNK 19537 TABLET
114718142 11471814 2 SS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 500 MG, BID 19537 500 MG TABLET BID
114718142 11471814 3 SS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 UNK 19537 TABLET
114718142 11471814 4 SS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 UNK 19537 TABLET
114718142 11471814 5 SS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 UNK 19537 TABLET
114718142 11471814 6 SS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 UNK 19537 TABLET
114718142 11471814 7 SS LEVAQUIN LEVOFLOXACIN 1 UNK 0
114718142 11471814 8 SS LEVAQUIN LEVOFLOXACIN 1 UNK 0
114718142 11471814 9 SS LEVAQUIN LEVOFLOXACIN 1 UNK 0
114718142 11471814 10 SS CIPROFLOXACIN. CIPROFLOXACIN 1 0
114718142 11471814 11 SS LEVAQUIN LEVOFLOXACIN 1 UNK 0
114718142 11471814 12 C VERAPAMIL VERAPAMIL HYDROCHLORIDE 1 0
114718142 11471814 13 C LUMIGAN BIMATOPROST 1 0
114718142 11471814 14 C GABAPENTIN. GABAPENTIN 1 0
114718142 11471814 15 C NAPROXEN. NAPROXEN 1 0
114718142 11471814 16 C MONTELUKAST MONTELUKAST SODIUM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114718142 11471814 1 Lower respiratory tract infection
114718142 11471814 2 Prostatic operation
114718142 11471814 3 Lower respiratory tract infection
114718142 11471814 4 Lower respiratory tract infection
114718142 11471814 5 Lower respiratory tract infection
114718142 11471814 6 Lower respiratory tract infection
114718142 11471814 7 Lung infection
114718142 11471814 8 Lung infection
114718142 11471814 9 Lung infection
114718142 11471814 10 Lung infection
114718142 11471814 12 Hypertension
114718142 11471814 13 Glaucoma
114718142 11471814 14 Pain
114718142 11471814 15 Pain
114718142 11471814 16 Asthma

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
114718142 11471814 Balance disorder
114718142 11471814 Emotional disorder
114718142 11471814 Emotional distress
114718142 11471814 Fall
114718142 11471814 Gait disturbance
114718142 11471814 Hypoaesthesia
114718142 11471814 Injury
114718142 11471814 Insomnia
114718142 11471814 Judgement impaired
114718142 11471814 Memory impairment
114718142 11471814 Neuropathy peripheral
114718142 11471814 Pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114718142 11471814 1 20060721 20060726 0
114718142 11471814 2 20080613 20080627 0
114718142 11471814 3 20080307 20080314 0
114718142 11471814 4 20080215 20080229 0
114718142 11471814 5 20071221 20071226 0
114718142 11471814 6 20071204 20071214 0
114718142 11471814 7 20060310 20060315 0
114718142 11471814 8 20071112 20071119 0
114718142 11471814 9 20070703 20070710 0
114718142 11471814 11 20060310 20060315 0